Paul Whitney
Vorstandsvorsitzender bei Parallel Private Equity LLP
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Neil Peters | M | - |
Parallel Private Equity LLP
 Parallel Private Equity LLP Investment ManagersFinance Parallel Private Equity LLP (Parallel Private Equity) is a private equity subsidiary of Parallel Private Equity Holdings Ltd. founded in 1997. The firm is headquartered in London. | 25 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Alexander Dunbar Morrison | M | - |
Phytopharm Plc
 Phytopharm Plc Pharmaceuticals: MajorHealth Technology Phytopharm Plc is a development stage pharmaceutical company, engaged in developing novel treatments targeting diseases with high levels of unmet need. Its products include Cogane and Myogane, used in therapy for neurodegenerative diseases including Parkinson's disease, amyotrophic lateral sclerosis and glaucoma. Phytopharm was founded on November 28, 1995 and is headquartered in Huntingdon, the United Kingdom. | 6 Jahre |
| Peter Robin Blower | M | 75 |
Phytopharm Plc
Phytopharm Plc Pharmaceuticals: MajorHealth Technology Phytopharm Plc is a development stage pharmaceutical company, engaged in developing novel treatments targeting diseases with high levels of unmet need. Its products include Cogane and Myogane, used in therapy for neurodegenerative diseases including Parkinson's disease, amyotrophic lateral sclerosis and glaucoma. Phytopharm was founded on November 28, 1995 and is headquartered in Huntingdon, the United Kingdom. | 7 Jahre |
| Yuk Fu Chen | M | 75 |
University of Aston
| 7 Jahre |
| Geoffrey Guy | M | 70 |
Phytopharm Plc
Phytopharm Plc Pharmaceuticals: MajorHealth Technology Phytopharm Plc is a development stage pharmaceutical company, engaged in developing novel treatments targeting diseases with high levels of unmet need. Its products include Cogane and Myogane, used in therapy for neurodegenerative diseases including Parkinson's disease, amyotrophic lateral sclerosis and glaucoma. Phytopharm was founded on November 28, 1995 and is headquartered in Huntingdon, the United Kingdom. | 8 Jahre |
| Alistair Taylor | M | - |
Phytopharm Plc
Phytopharm Plc Pharmaceuticals: MajorHealth Technology Phytopharm Plc is a development stage pharmaceutical company, engaged in developing novel treatments targeting diseases with high levels of unmet need. Its products include Cogane and Myogane, used in therapy for neurodegenerative diseases including Parkinson's disease, amyotrophic lateral sclerosis and glaucoma. Phytopharm was founded on November 28, 1995 and is headquartered in Huntingdon, the United Kingdom. | 6 Jahre |
| Zoe Karen McGowan | F | - |
Phytopharm Plc
Phytopharm Plc Pharmaceuticals: MajorHealth Technology Phytopharm Plc is a development stage pharmaceutical company, engaged in developing novel treatments targeting diseases with high levels of unmet need. Its products include Cogane and Myogane, used in therapy for neurodegenerative diseases including Parkinson's disease, amyotrophic lateral sclerosis and glaucoma. Phytopharm was founded on November 28, 1995 and is headquartered in Huntingdon, the United Kingdom. | 13 Jahre |
| Graham S. Cox | M | 61 |
Parallel Private Equity LLP
Parallel Private Equity LLP Investment ManagersFinance Parallel Private Equity LLP (Parallel Private Equity) is a private equity subsidiary of Parallel Private Equity Holdings Ltd. founded in 1997. The firm is headquartered in London. | 16 Jahre |
| Yee Tak Leung | M | 75 |
University of Aston
| 1 Jahre |
| Kai Ming Choi | M | 74 |
University of Aston
| 4 Jahre |
| George C. Hancock | M | 79 |
Cranfield University
| 2 Jahre |
| Alan Bowen | M | - |
Parallel Private Equity LLP
Parallel Private Equity LLP Investment ManagersFinance Parallel Private Equity LLP (Parallel Private Equity) is a private equity subsidiary of Parallel Private Equity Holdings Ltd. founded in 1997. The firm is headquartered in London. | 5 Jahre |
| Howard Sinclair-Jones | M | - |
University of Aston
| 3 Jahre |
| Mahadev Raman | M | - |
Cranfield University
| 1 Jahre |
| Tai-Chiu Lee | M | 79 |
University of Aston
| 3 Jahre |
| Liyanarachige Tillekeratne | M | - |
University of Aston
| 1 Jahre |
| Paul Cyril Warwick | M | 71 |
Cranfield University
| 1 Jahre |
| Ahmad Khayyat | M | - |
University of Aston
| 4 Jahre |
| Michael Wright | M | 70 |
University of Aston
| 3 Jahre |
| Ah Kiow Fu | M | 76 |
Cranfield University
| 1 Jahre |
| Alan Moore | M | - |
University of Aston
| 3 Jahre |
| Stephen Leftly | M | - |
University of Aston
| 4 Jahre |
| Nick Rouse | M | - |
University of Aston
| 4 Jahre |
| Farhan Sharaff | M | - |
University of Aston
| 3 Jahre |
| J. Graham Eacott | M | - |
University of Aston
| 1 Jahre |
| Trevor H. Flanagan | M | - |
Phytopharm Plc
Phytopharm Plc Pharmaceuticals: MajorHealth Technology Phytopharm Plc is a development stage pharmaceutical company, engaged in developing novel treatments targeting diseases with high levels of unmet need. Its products include Cogane and Myogane, used in therapy for neurodegenerative diseases including Parkinson's disease, amyotrophic lateral sclerosis and glaucoma. Phytopharm was founded on November 28, 1995 and is headquartered in Huntingdon, the United Kingdom. | - |
| Gordon K. G. Stevens | M | - |
Phytopharm Plc
Phytopharm Plc Pharmaceuticals: MajorHealth Technology Phytopharm Plc is a development stage pharmaceutical company, engaged in developing novel treatments targeting diseases with high levels of unmet need. Its products include Cogane and Myogane, used in therapy for neurodegenerative diseases including Parkinson's disease, amyotrophic lateral sclerosis and glaucoma. Phytopharm was founded on November 28, 1995 and is headquartered in Huntingdon, the United Kingdom. | - |
| Richard Peter Dixey | M | - |
Phytopharm Plc
Phytopharm Plc Pharmaceuticals: MajorHealth Technology Phytopharm Plc is a development stage pharmaceutical company, engaged in developing novel treatments targeting diseases with high levels of unmet need. Its products include Cogane and Myogane, used in therapy for neurodegenerative diseases including Parkinson's disease, amyotrophic lateral sclerosis and glaucoma. Phytopharm was founded on November 28, 1995 and is headquartered in Huntingdon, the United Kingdom. | - |
| Grant Haggith | M | - |
Parallel Private Equity LLP
Parallel Private Equity LLP Investment ManagersFinance Parallel Private Equity LLP (Parallel Private Equity) is a private equity subsidiary of Parallel Private Equity Holdings Ltd. founded in 1997. The firm is headquartered in London. | 14 Jahre |
| Alastair Graham Donald | M | 70 |
Cranfield University
| 2 Jahre |
| Christopher Charles Allner | M | 65 |
3i Plc
 3i Plc Financial ConglomeratesFinance 3i Plc operates as an private equity firm and provides investment advice. The company was founded on July 21, 1945 and is headquartered in London, the United Kingdom. | - |
| Piers John Morgan | M | 57 |
Phytopharm Plc
Phytopharm Plc Pharmaceuticals: MajorHealth Technology Phytopharm Plc is a development stage pharmaceutical company, engaged in developing novel treatments targeting diseases with high levels of unmet need. Its products include Cogane and Myogane, used in therapy for neurodegenerative diseases including Parkinson's disease, amyotrophic lateral sclerosis and glaucoma. Phytopharm was founded on November 28, 1995 and is headquartered in Huntingdon, the United Kingdom. | 1 Jahre |
| John Mackie | M | 70 |
Parallel Private Equity LLP
Parallel Private Equity LLP Investment ManagersFinance Parallel Private Equity LLP (Parallel Private Equity) is a private equity subsidiary of Parallel Private Equity Holdings Ltd. founded in 1997. The firm is headquartered in London. | 9 Jahre |
| Colin Stott | M | 57 |
Phytopharm Plc
Phytopharm Plc Pharmaceuticals: MajorHealth Technology Phytopharm Plc is a development stage pharmaceutical company, engaged in developing novel treatments targeting diseases with high levels of unmet need. Its products include Cogane and Myogane, used in therapy for neurodegenerative diseases including Parkinson's disease, amyotrophic lateral sclerosis and glaucoma. Phytopharm was founded on November 28, 1995 and is headquartered in Huntingdon, the United Kingdom. | 3 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigtes Königreich | 34 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Paul Whitney
- Persönliches Netzwerk
